About 2% of global population suffers from OCD, of which only about 10% are receiving treatment.
Among CBT*, ERP** is first-line treatment for OCD, however, only 50% experience an improvement in OCD symptoms and the dropout rate is about 25%.
*Cognitive Behavioral Therapy
**Exposure and Response Prevention
OC Free not only improves the accessibility and effectiveness of existing OCD Treatments, but enhances the QOL* of patients through digitalized ERP treatment.
*Quality of Life
BIXINK strives to be a pioneer in developing Korea's first FDA-approved digital therapeutics, and is currently pursuing pilot study in the United States
CAUTION: Investigational Device. Limited by Federal law to investigational use.
OC Free®
Investigational SaMD for contamination OCD*
*Obsessive Compulsive Disorder
Development Status
Stage 1....
Domestic Pilot study....
Stage 2
US Pilot study
.....Stage 3
.....US Pivotal study
BIXINK strives to be a pioneer in developing Korea's first FDA-approved digital therapeutics, and is currently pursuing pilot study in the United States
